Bio-Path Holdings, Inc. (BPTH) Financials

BPTH Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 3.2 million 2.8 million
2023-09-30 5.0 million 2.5 million
2023-06-30 6.5 million 1.5 million
2023-03-31 11.1 million 2.0 million

BPTH Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -1.8 million 180000
2023-09-30 -2.8 million 178000
2023-06-30 -3.3 million 170000
2023-03-31 -3.7 million 206000

BPTH Net Income

No data available :(

BPTH Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 1.1 million - 113000
2023-09-30 2.4 million - 141000
2023-06-30 3.4 million - 168000
2023-03-31 6.7 million - 195000

BPTH Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 618000
2023-09-30 10.1 million
2023-06-30 8.0 million
2023-03-31 8.0 million

BPTH Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 2.3 million 757000 -
2023-09-30 - 2.3 million 984000 -
2023-06-30 - 3.1 million 1.2 million -
2023-03-31 - 4.0 million 1.3 million -

BPTH Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 41000
2023-09-30 - 46000
2023-06-30 - 46000
2023-03-31 - 45000

BPTH

Price: $2.61

52 week price:
2.49
44.80

Earnings Per Share: -33.63 USD

P/E Ratio: -0.23

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 19400

Ebitda: -4.6 million

Market Capitalization: 2.3 million

Links: